BJU International

Cover image for Vol. 117 Issue 6B

Early View (Online Version of Record published before inclusion in an issue)

Edited By: Prokar Dasgupta

Impact Factor: 3.533

ISI Journal Citation Reports © Ranking: 2014: 14/78 (Urology & Nephrology)

Online ISSN: 1464-410X

VIEW

  1. 1 - 100
  2. 101 - 111
  1. Original Articles

    1. Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre

      Vincent J. Gnanapragasam, David Thurtle, Anandagopal Srinivasan, Dimitrios Volanis, Anne George, Artitaya Lophatananon, Sara Stearn, Anne Y. Warren, Alastair D. Lamb, Greg Shaw, Naomi Sharma, Ben C. Thomas, Maxine G. Tran, David E. Neal and Nimish C. Shah

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/bju.13513

    2. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer

      Andrei Fodor, Genoveffa Berardi, Claudio Fiorino, Maria Picchio, Elena Busnardo, Margarita Kirienko, Elena Incerti, Italo Dell'Oca, Cesare Cozzarini, Paola Mangili, Marcella Pasetti, Riccardo Calandrino, Luigi Gianolli and Nadia G Di Muzio

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/bju.13510

  2. Comments

    1. You have free access to this content
      Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC)

      Leonard P. Bokhorst, Marco Zappa, Sigrid V. Carlsson, Maciej Kwiatkowski, Louis Denis, Alvaro Paez, Jonas Hugosson, Sue Moss, Anssi Auvinen and Monique J. Roobol

      Version of Record online: 20 MAY 2016 | DOI: 10.1111/bju.13505

  3. Original Articles

    1. Detecting positive surgical margins: utilisation of light-reflectance spectroscopy on ex vivo prostate specimens

      Aaron H. Lay, Xinlong Wang, Monica S. C. Morgan, Payal Kapur, Hanli Liu, Claus G. Roehrborn and Jeffrey A. Cadeddu

      Version of Record online: 20 MAY 2016 | DOI: 10.1111/bju.13503

    2. Attitudes and knowledge of urethral catheters: a targeted educational intervention

      Andrew Cohen, Charles Nottingham, Vignesh Packiam, Nora Jaskowiak and Mohan Gundeti

      Version of Record online: 18 MAY 2016 | DOI: 10.1111/bju.13506

    3. Robot-assisted technique for Boari flap ureteric reimplantation: replicating the techniques of open surgery in robotics

      Jens-Uwe Stolzenburg, Bhavan P Rai, Minh Do, Anja Dietel, Evangelos Liatsikos, Roman Ganzer, Hasan Qazi, Aurus Dourado Meneses and Panagiotis Kallidonis

      Version of Record online: 17 MAY 2016 | DOI: 10.1111/bju.13502

    4. Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder

      Jing Leng, Limin Liao, Ben Wan, Chuanjun Du, Wei Li, Keji Xie, Zhoujun Shen, Zhuoqun Xu, Shiliang Wu, Zujun Fang, Lulin Ma, Shaomei Han, Cornelia Feustel, Yong Yang and Helmut Madersbacher

      Version of Record online: 13 MAY 2016 | DOI: 10.1111/bju.13500

  4. Reviews

    1. You have full text access to this OnlineOpen article
      Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review

      Penny F. Whiting, Theresa H.M. Moore, Catherine M. Jameson, Philippa Davies, Mari-Anne Rowlands, Margaret Burke, Rebecca Beynon, Jelena Savovic and Jenny L. Donovan

      Version of Record online: 13 MAY 2016 | DOI: 10.1111/bju.13499

  5. Original Articles

    1. Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

      Zachary Hamilton, Hak J. Lee, Juan Jimenez, Brian R. Lane, Song Wang, Alp T. Beksac, Kyle Gillis, Amy Alagh, Conrad Tobert, James M. Randall, Christopher J. Kane, Frederick Millard, Steven C. Campbell and Ithaar H. Derweesh

      Version of Record online: 11 MAY 2016 | DOI: 10.1111/bju.13490

  6. Reviews

    1. Guidelines of guidelines: thromboprophylaxis for urological surgery

      Philippe D. Violette, Rufus Cartwright, Matthias Briel, Kari A.O. Tikkinen and Gordon H. Guyatt

      Version of Record online: 29 APR 2016 | DOI: 10.1111/bju.13496

  7. Original Articles

    1. Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy

      Matthias M. Heck, Markus A. Thaler, Sebastian C. Schmid, Anna-Katharina Seitz, Robert Tauber, Hubert Kübler, Tobias Maurer, Mark Thalgott, Georgios Hatzichristodoulou, Michael Höppner, Roman Nawroth, Peter B. Luppa, Jürgen E. Gschwend and Margitta Retz

      Version of Record online: 27 APR 2016 | DOI: 10.1111/bju.13493

  8. Comments

    1. You have full text access to this OnlineOpen article
      Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

      Christel Häggström, Pär Stattin, Tanja Stocks, Hans Garmo, Lars Holmberg and Mieke Van Hemelrijck

      Version of Record online: 24 APR 2016 | DOI: 10.1111/bju.13494

  9. Original Articles

    1. You have free access to this content
    2. Independent surgical validation of the new prostate cancer grade-grouping system

      Daniel E. Spratt, Adam I. Cole, Ganesh S. Palapattu, Alon Z. Weizer, William C. Jackson, Jeffrey S. Montgomery, Robert T. Dess, Shuang G. Zhao, Jae Y. Lee, Angela Wu, Lakshmi P. Kunju, Emily Talmich, David C. Miller, Brent K. Hollenbeck, Scott A. Tomlins, Felix Y. Feng, Rohit Mehra and Todd M. Morgan

      Version of Record online: 19 APR 2016 | DOI: 10.1111/bju.13488

    3. Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate?

      Roger Valdivieso, Christian P Meyer, Pierre-Alain Hueber, Malek Meskawi, Abdullah M. Alenizi, Mounsif Azizi, Quoc-Dien Trinh, Vincent Misrai, Matthew Rutman, Alexis E. Te, Bilal Chughtai, Neil J. Barber, Amr M. Emara, Ravi Munver and Kevin C. Zorn

      Version of Record online: 16 APR 2016 | DOI: 10.1111/bju.13479

    4. You have full text access to this OnlineOpen article
      Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancer

      Neal D. Shore, Franklin Chu, Judd Moul, Daniel Saltzstein, Raoul Concepcion, John A. McLane, Stuart Atkinson, Alex Yang and E. David Crawford

      Version of Record online: 16 APR 2016 | DOI: 10.1111/bju.13482

  10. Reviews

    1. Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta-analysis

      Angelica A.C. Grasso, Francesco A. Mistretta, Marco Sandri, Gabriele Cozzi, Elisa De Lorenzis, Marco Rosso, Giancarlo Albo, Franco Palmisano, Alex Mottrie, Alexander Haese, Markus Graefen, Rafael Coelho, Vipul R. Patel and Bernardo Rocco

      Version of Record online: 7 APR 2016 | DOI: 10.1111/bju.13480

  11. Original Articles

    1. Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare

      Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Keijiro Kiyoshima, Junichi Inokuchi, Katsunori Tatsugami, Ken-ichiro Shiga, Hirofumi Koga, Akito Yamaguchi, Seiji Naito and Masatoshi Eto

      Version of Record online: 6 APR 2016 | DOI: 10.1111/bju.13483

    2. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study

      Romain Mathieu, Ilaria Lucca, Mihai D. Vartolomei, Aurélie Mbeutcha, Tobias Klatte, Christian Seitz, Pierre I. Karakiewicz, Harun Fajkovic, Maxine Sun, Yair Lotan, Francesco Montorsi, Alberto Briganti, Morgan Rouprêt, Vitaly Margulis, Michael Rink, Malte Rieken, Lukas Kenner, Martin Susani, Loidl Wolgang and Shahrokh F. Shariat

      Version of Record online: 5 APR 2016 | DOI: 10.1111/bju.13472

    3. Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy

      Nicola Longo, Ciro Imbimbo, Ferdinando Fusco, Vincenzo Ficarra, Francesco Mangiapia, Giuseppe Di Lorenzo, Massimiliano Creta, Vittorio Imperatore and Vincenzo Mirone

      Version of Record online: 4 APR 2016 | DOI: 10.1111/bju.13462

  12. Comments

    1. You have free access to this content
  13. Original Articles

    1. The safety of robot-assisted cystectomy in patients with previous history of pelvic irradiation

      Bashir Al Hussein Al Awamlh, Daniel P. Nguyen, Brandon Otto, Padraic O'Malley, Farehin Khan, Savanah Brooks and Douglas S. Scherr

      Version of Record online: 2 APR 2016 | DOI: 10.1111/bju.13464

    2. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy

      Angelika Borkowetz, Ivan Platzek, Marieta Toma, Theresa Renner, Roman Herout, Martin Baunacke, Michael Laniado, Gustavo Baretton, Michael Froehner, Stefan Zastrow and Manfred Wirth

      Version of Record online: 2 APR 2016 | DOI: 10.1111/bju.13461

  14. Comments

    1. You have free access to this content
      Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated

      Roderick C.N. van den Bergh, Theo H. van der Kwast, Jeroen de Jong, Homayoun Zargar, Andrew J. Ryan, Anthony J. Costello, Declan G. Murphy and Henk G. van der Poel

      Version of Record online: 1 APR 2016 | DOI: 10.1111/bju.13478

  15. Original Articles

    1. You have full text access to this OnlineOpen article
    2. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases

      Yan Shibing, Liu Liangren, Wei Qiang, Liao Hong, Song Turun, Lei Junhao, Yang Lu, Yuan Zhengyong, Jiang Yonghao, Fu Guangqing, Li Yunxiang and Cao Dehong

      Version of Record online: 27 MAR 2016 | DOI: 10.1111/bju.13463

    3. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000–2012

      Daniela Danneman, Linda Drevin, Brett Delahunt, Hemamali Samaratunga, David Robinson, Ola Bratt, Stacy Loeb, Pär Stattin and Lars Egevad

      Version of Record online: 24 MAR 2016 | DOI: 10.1111/bju.13458

    4. Technical mentorship during robot-assisted surgery: a cognitive analysis

      Ahmed A. Hussein, Somayeh B. Shafiei, Mohamed Sharif, Ehsan Esfahani, Basel Ahmad, Justen D. Kozlowski, Zishan Hashmi and Khurshid A. Guru

      Version of Record online: 24 MAR 2016 | DOI: 10.1111/bju.13445

    5. Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy

      Alexandre de la Taille, Luis Martínez-Piñeiro, Patrick Cabri, Aude Houchard, Jack Schalken and on behalf of the Triptocare LT Study Group

      Version of Record online: 23 MAR 2016 | DOI: 10.1111/bju.13455

    6. Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinence

      Sascha A. Ahyai, Tim A. Ludwig, Roland Dahlem, Armin Soave, Clemens Rosenbaum, Felix K-H. Chun, Margit Fisch, Marianne Schmid and Luis A. Kluth

      Version of Record online: 22 MAR 2016 | DOI: 10.1111/bju.13449

    7. Mid-term outcomes after AdVanceXP male sling implantation

      Alexander Kretschmer, Markus Grabbert, Anne Sommer, Christian G. Stief and Ricarda M. Bauer

      Version of Record online: 19 MAR 2016 | DOI: 10.1111/bju.13459

    8. Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensus

      Andreas Maxeiner, Ahmed Magheli, Korinna Jöhrens, Ergin Kilic, Tom Lukas Braun, Carsten Kempkensteffen, Stefan Hinz, Carsten Stephan, Kurt Miller and Jonas Busch

      Version of Record online: 19 MAR 2016 | DOI: 10.1111/bju.13451

    9. Admissions to hospital due to fracture in England in patients with prostate cancer treated with androgen-deprivation therapy – do we have to worry about the hormones?

      Edward R. Jefferies, Amit Bahl, Luke Hounsome, Maike F. Eylert, Julia Verne, Raj A. Persad and on behalf of the PHONIC collaborative

      Version of Record online: 19 MAR 2016 | DOI: 10.1111/bju.13441

    10. Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial

      Stefan Carlsson, Fredrik Jäderling, Anna Wallerstedt, Tommy Nyberg, Johan Stranne, Thordis Thorsteinsdottir, Sigrid V. Carlsson, Anders Bjartell, Jonas Hugosson, Eva Haglind and Gunnar Steineck

      Version of Record online: 18 MAR 2016 | DOI: 10.1111/bju.13444

  16. Comments

    1. You have free access to this content
    2. You have free access to this content
  17. Original Articles

    1. Initial experience of an algorithm-based protocol for the community follow-up of men with prostate cancer

      Philip P. Goodall, Jessica Little, Eleanor Robinson, Ian Trimble, Owen J. Cole and Thomas J. Walton

      Version of Record online: 12 MAR 2016 | DOI: 10.1111/bju.13446

    2. Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence

      Sarah M. Rudman, Kathryn P. Gray, Julie L. Batista, Michael J. Pitt, Edward L. Giovannucci, Peter G. Harper, Massimo Loda, Lorelei A. Mucci and Christopher J. Sweeney

      Version of Record online: 8 MAR 2016 | DOI: 10.1111/bju.13428

    3. European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study

      Robert W. Foley, Robert M. Maweni, Laura Gorman, Keefe Murphy, Dara J. Lundon, Garrett Durkan, Richard Power, Frank O'Brien, Kieran J. O'Malley, David J. Galvin, T. Brendan Murphy and R. William Watson

      Version of Record online: 29 FEB 2016 | DOI: 10.1111/bju.13437

    4. Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohorts

      Andrew J. Simpkin, Jenny L. Donovan, Kate Tilling, J. Athene Lane, Richard M. Martin, Peter C. Albertsen, Anna Bill-Axelson, H. Ballentine Carter, J. L. H Ruud Bosch, Luigi Ferrucci, Freddie C. Hamdy, Lars Holmberg, E. Jeffrey Metter, David E. Neal, Christopher C. Parker and Chris Metcalfe

      Version of Record online: 29 FEB 2016 | DOI: 10.1111/bju.13422

  18. Comments

    1. You have free access to this content
  19. Original Articles

    1. Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results

      James S. Wysock, Neil Mendhiratta, Fabio Zattoni, Xiaosong Meng, Marc Bjurlin, William C. Huang, Herbert Lepor, Andrew B. Rosenkrantz and Samir S. Taneja

      Version of Record online: 25 FEB 2016 | DOI: 10.1111/bju.13427

    2. Impact of the lack of community urinary catheter care services on the Emergency Department

      Li June Tay, Hannah Lyons, Irene Karrouze, Claire Taylor, Azhar A. Khan and Peter M. Thompson

      Version of Record online: 25 FEB 2016 | DOI: 10.1111/bju.13430

    3. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers

      Sung Yoon Park, Young Taik Oh, Dae Chul Jung, Nam Hoon Cho, Young Deuk Choi, Koon Ho Rha and Sung Joon Hong

      Version of Record online: 24 FEB 2016 | DOI: 10.1111/bju.13436

    4. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis

      Peter Boyle, Alice Koechlin, Maria Bota, Alberto d'Onofrio, David G. Zaridze, Paul Perrin, John Fitzpatrick, Arthur L. Burnett and Mathieu Boniol

      Version of Record online: 24 FEB 2016 | DOI: 10.1111/bju.13417

    5. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model

      Boris Gershman, Naoki Takahashi, Daniel M. Moreira, Robert H. Thompson, Stephen A. Boorjian, Christine M. Lohse, Brian A. Costello, John C. Cheville and Bradley C. Leibovich

      Version of Record online: 23 FEB 2016 | DOI: 10.1111/bju.13424

    6. A prospective study of the short-term quality-of-life outcomes of patients undergoing transperineal prostate biopsy

      Adam S. Dowrick, Addie C. Wootten, Nicholas Howard, Justin S. Peters and Declan G. Murphy

      Version of Record online: 23 FEB 2016 | DOI: 10.1111/bju.13413

    7. MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1

      Chao Zhang, Xin Ma, Jun Du, Zhiyong Yao, Taoping Shi, Qing Ai, Xusheng Chen, Zhenting Zhang, Xu Zhang and Xin Yao

      Version of Record online: 21 FEB 2016 | DOI: 10.1111/bju.13407

    8. Ambulatory movements, team dynamics and interactions during robot-assisted surgery

      Nabeeha Ahmad, Ahmed A. Hussein, Lora Cavuoto, Mohamed Sharif, Jenna C. Allers, Nobuyuki Hinata, Basel Ahmad, Justen D. Kozlowski, Zishan Hashmi, Ann Bisantz and Khurshid A. Guru

      Version of Record online: 21 FEB 2016 | DOI: 10.1111/bju.13426

    9. Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma

      Jun Obata, Nobuyuki Tanaka, Ryuichi Mizuno, Kent Kanao, Shuji Mikami, Kazuhiro Matsumoto, Takeo Kosaka, Eiji Kikuchi, Masahiro Jinzaki and Mototsugu Oya

      Version of Record online: 19 FEB 2016 | DOI: 10.1111/bju.13414

    10. Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer

      Ravi A. Madan, Fatima H. Karzai, Yang-Min Ning, Bamidele A. Adesunloye, Xuan Huang, Nancy Harold, Anna Couvillon, Guinevere Chun, Lisa Cordes, Tristan Sissung, Shaunna L. Beedie, Nancy A. Dawson, Marc R. Theoret, David G. McLeod, Inger Rosner, Jane B. Trepel, Min-Jung Lee, Yusuke Tomita, Sunmin Lee, Clara Chen, Seth M. Steinberg, Philip M. Arlen, James L. Gulley, William D. Figg and William L. Dahut

      Version of Record online: 19 FEB 2016 | DOI: 10.1111/bju.13412

  20. Comments

    1. You have free access to this content
  21. Original Articles

    1. The incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissection

      Mehmet Selcuk Keskin, Ömer Burak Argun, Can Öbek, Ilter Tufek, Mustafa Bilal Tuna, Panogiotis Mourmouris, Sarper Erdoğan and Ali Rıza Kural

      Version of Record online: 17 FEB 2016 | DOI: 10.1111/bju.13425

    2. Percutaneous nephrolithotomy for staghorn stones: a randomised trial comparing high-power holmium laser versus ultrasonic lithotripsy

      Ahmed R. EL-Nahas, Ahmed M. Elshal, Nasr A. EL-Tabey, Ahmed M. EL-Assmy and Ahmed A. Shokeir

      Version of Record online: 16 FEB 2016 | DOI: 10.1111/bju.13418

    3. Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study

      Johan Björklund, Yasin Folkvaljon, Alexander Cole, Stefan Carlsson, David Robinson, Stacy Loeb, Pär Stattin and Olof Akre

      Version of Record online: 15 FEB 2016 | DOI: 10.1111/bju.13404

    4. Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery

      Newaj Abdullah, Haider Rahbar, Ravi Barod, Deepansh Dalela, Jeff Larson, Michael Johnson, Alon Mass, Homayoun Zargar, Mohamad Allaf, Sam Bhayani, Michael Stifelman, Jihad Kaouk and Craig Rogers

      Version of Record online: 15 FEB 2016 | DOI: 10.1111/bju.13408

    5. Do stones still kill? An analysis of death from stone disease 1999–2013 in England and Wales

      Francesca Kum, Wasim Mahmalji, Jemma Hale, Kay Thomas, Matthew Bultitude and Jonathan Glass

      Version of Record online: 12 FEB 2016 | DOI: 10.1111/bju.13409

    6. Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study

      Leonard P. Bokhorst, Inari Lepistö, Yoshiyuki Kakehi, Chris H. Bangma, Tom Pickles, Riccardo Valdagni, Arnout R. Alberts, Axel Semjonow, Petra Strölin, Manuel F. Montesino, Viktor Berge, Monique J. Roobol and Antti Rannikko

      Version of Record online: 12 FEB 2016 | DOI: 10.1111/bju.13410

    7. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness

      Tine M. Storebjerg, Søren Høyer, Pia Kirkegaard, Flemming Bro, the LuCamp Study Group, Torben F. Ørntoft, Michael Borre and Karina D. Sørensen

      Version of Record online: 12 FEB 2016 | DOI: 10.1111/bju.13416

    8. Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma

      Emmanuel Seront, Sylvie Rottey, Bertrand Filleul, Philippe Glorieux, Jean-Charles Goeminne, Vincent Verschaeve, Jean-Marie Vandenbulcke, Brieuc Sautois, Petra Boegner, Aline Gillain, Aline van Maanen and Jean-Pascal Machiels

      Version of Record online: 11 FEB 2016 | DOI: 10.1111/bju.13415

    9. Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer

      Stephen J. Freedland, Lauren E. Howard, Brian T. Hanyok, Vishnu K. Kadiyala, Jameson Y. Kuang, Colette A. Whitney, Floyd R. Wilks, Christopher J. Kane, Martha K. Terris, Christopher L. Amling, Matthew R. Cooperberg, William J. Aronson and Daniel M. Moreira

      Version of Record online: 8 FEB 2016 | DOI: 10.1111/bju.13405

  22. Comments

    1. You have free access to this content
      Will chemotherapy change the management of prostate cancer?

      Clare Gilson, Matthew R. Sydes and Simon Chowdhury

      Version of Record online: 22 JAN 2016 | DOI: 10.1111/bju.13400

  23. Original Articles

    1. A survey of patient expectations regarding sexual function following radical prostatectomy

      Serkan Deveci, Geoffrey T. Gotto, Byron Alex, Keith O'Brien and John P. Mulhall

      Version of Record online: 17 JAN 2016 | DOI: 10.1111/bju.13398

    2. Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in patients with penile squamous cell carcinoma

      Zai-Shang Li, Kai Yao, Yong-Hong Li, Jie-Ping Chen, Chuang-Zhong Deng, Qi Zhao, Peng Chen, Bin Wang, Qi-Wu Mi, Zhuo-Wei Liu, Zi-Ke Qin, Hui Han and Fang-Jian Zhou

      Version of Record online: 27 DEC 2015 | DOI: 10.1111/bju.13379

    3. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer

      Michael L. Blute Jr, Kristin Zorn, Matthew Grimes, Fangfang Shi, Tracy M. Downs, David F. Jarrard, Sara L. Best, Kyle Richards, Stephen Y. Nakada and E. Jason Abel

      Version of Record online: 22 DEC 2015 | DOI: 10.1111/bju.13381

    4. Multiphoton microscopy for rapid histopathological evaluation of kidney tumours

      Manu Jain, Brian D. Robinson, Amit Aggarwal, Maria M. Shevchuk, Douglas S. Scherr and Sushmita Mukherjee

      Version of Record online: 14 DEC 2015 | DOI: 10.1111/bju.13377

    5. Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience

      Marc R. Matrana, Tharakeswara Bathala, Matthew T. Campbell, Cihan Duran, Aditya Shetty, Purnima Teegavarapu, Sarathi Kalra, Lianchun Xiao, Bradley Atkinson, Paul Corn, Eric Jonasch and Nizar M. Tannir

      Version of Record online: 13 DEC 2015 | DOI: 10.1111/bju.13374

    6. Trends in stage-specific incidence of prostate cancer in Norway, 1980–2010: a population-based study

      Mette H. Møller, Ivar S. Kristiansen, Christian Beisland, Jarle Rørvik and Henrik Støvring

      Version of Record online: 24 NOV 2015 | DOI: 10.1111/bju.13364

    7. Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy

      Sean O'Farrell, Karin Sandström, Hans Garmo, Pär Stattin, Lars Holmberg, Jan Adolfsson and Mieke Van Hemelrijck

      Version of Record online: 19 NOV 2015 | DOI: 10.1111/bju.13360

    8. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients

      Joris Muller, Pascale Grosclaude, Bénédicte Lapôtre-Ledoux, Anne-Sophie Woronoff, Anne-Valérie Guizard, Simona Bara, Marc Colonna, Xavier Troussard, Véronique Bouvier, Brigitte Trétarre, Michel Velten and Jérémie Jégu

      Version of Record online: 17 NOV 2015 | DOI: 10.1111/bju.13351

  24. Comments

    1. You have free access to this content
      Pioglitazone and bladder cancer

      Hannah Warren, Nicholas Raison and Prokar Dasgupta

      Version of Record online: 14 NOV 2015 | DOI: 10.1111/bju.13352

  25. Original Articles

    1. Extent of renal vein invasion influences prognosis in patients with renal cell carcinoma

      Mark W. Ball, Michael A. Gorin, Kelly T. Harris, Kevin M. Curtiss, George J. Netto, Christian P. Pavlovich, Phillip M. Pierorazio and Mohamad E. Allaf

      Version of Record online: 14 NOV 2015 | DOI: 10.1111/bju.13349

    2. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin

      Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Marco Oderda, Vincenzo Serretta, Stéphane Larré, Savino Di Stasi, Bas Van Rhijn, Alfred J. Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, Marek Babjuk, Viktor Soukup, Per-Uno Malmström, Jacques Irani, Nuria Malats, Jack Baniel, Roy Mano, Tommaso Cai, Eugene K. Cha, Peter Ardelt, John Vakarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Evanguelos Xylinas, Robert J. Karnes and Joan Palou

      Version of Record online: 6 NOV 2015 | DOI: 10.1111/bju.13354

  26. Comments

    1. You have free access to this content
      Advances in advanced prostate cancer – the continuing journey

      Heather Payne, Reena Davda, Robert Jones, Simon Crabb, Janis Troup and Simon Hughes

      Version of Record online: 4 NOV 2015 | DOI: 10.1111/bju.13350

  27. Original Articles

    1. Outcomes of living donor renal transplantation in children with lower urinary tract dysfunction: a comparative retrospective study

      Ismail R. Saad, Enmar Habib, Mohammed S. ElSheemy, Mahmoud Abdel-Hakim, Mostafa Sheba, Aziz Mosleh, Doaa M. Salah, Hafez Bazaraa, Fatina I. Fadel, Hany A. Morsi and Hesham Badawy

      Version of Record online: 2 NOV 2015 | DOI: 10.1111/bju.13347

  28. Urological Oncology

    1. Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care

      Jennifer K. Bernat, Daniela A. Wittman, Sarah T. Hawley, Daniel A. Hamstra, Alexander M. Helfand, David A. Haggstrom, May Darwish-Yassine and Ted A. Skolarus

      Version of Record online: 26 OCT 2015 | DOI: 10.1111/bju.13329

  29. Original Articles

    1. Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance

      Behfar Ehdaie, Bing Ying Poon, Daniel D. Sjoberg, Pedro Recabal, Vincent Laudone, Karim Touijer, James Eastham and Peter T. Scardino

      Version of Record online: 26 OCT 2015 | DOI: 10.1111/bju.13328

    2. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure

      Hannes Cash, Karsten Günzel, Andreas Maxeiner, Carsten Stephan, Thomas Fischer, Tahir Durmus, Kurt Miller, Patrick Asbach, Matthias Haas and Carsten Kempkensteffen

      Version of Record online: 20 OCT 2015 | DOI: 10.1111/bju.13327

    3. Population-based assessment of cancer-specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis

      Alessandro Larcher, Vincent Trudeau, Maxine Sun, Katharina Boehm, Malek Meskawi, Zhe Tian, Nicola Fossati, Paolo Dell'Oglio, Umberto Capitanio, Alberto Briganti, Shahrokh F. Shariat, Francesco Montorsi and Pierre I. Karakiewicz

      Version of Record online: 16 OCT 2015 | DOI: 10.1111/bju.13326

  30. Comments

    1. You have free access to this content
  31. Original Articles

    1. Do all men with pathological Gleason score 8–10 prostate cancer have poor outcomes? Results from the SEARCH database

      Sean Fischer, Daniel Lin, Ross M. Simon, Lauren E. Howard, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matt R. Cooperberg, Stephen J. Freedland and Adriana C. Vidal

      Version of Record online: 8 OCT 2015 | DOI: 10.1111/bju.13319

    2. Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer

      Massimo Valerio, Chukwuemeka Anele, Susan C. Charman, Jan van der Meulen, Alex Freeman, Charles Jameson, Paras B. Singh, Mark Emberton and Hashim U. Ahmed

      Version of Record online: 25 SEP 2015 | DOI: 10.1111/bju.13306

    3. Suicide and accidental deaths among patients with non-metastatic prostate cancer

      Deepansh Dalela, Nandita Krishna, James Okwara, Mark A. Preston, Firas Abdollah, Toni K. Choueiri, Gally Reznor, Jesse D. Sammon, Marianne Schmid, Adam S. Kibel, Paul L. Nguyen, Mani Menon and Quoc-Dien Trinh

      Version of Record online: 19 SEP 2015 | DOI: 10.1111/bju.13257

    4. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy

      Daniel M. Moreira, Boris Gershman, Laureano J. Rangel, Stephen A. Boorjian, Robert Houston Thompson, Igor Frank, Matthew K. Tollefson, Matthew T. Gettman and Robert Jeffrey Karnes

      Version of Record online: 16 SEP 2015 | DOI: 10.1111/bju.13266

    5. Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer

      Vinayak Muralidhar, Brandon A. Mahal, Michelle D. Nezolosky, Clair J. Beard, Felix Y. Feng, Neil E. Martin, Jason A. Efstathiou, Toni K. Choueiri, Mark M. Pomerantz, Christopher J. Sweeney, Quoc-Dien Trinh, Matthew G. Vander Heiden and Paul L. Nguyen

      Version of Record online: 31 AUG 2015 | DOI: 10.1111/bju.13248

    6. Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard

      Filippo Russo, Daniele Regge, Enrico Armando, Valentina Giannini, Anna Vignati, Simone Mazzetti, Matteo Manfredi, Enrico Bollito, Loredana Correale and Francesco Porpiglia

      Version of Record online: 24 AUG 2015 | DOI: 10.1111/bju.13234

VIEW

  1. 1 - 100
  2. 101 - 111

SEARCH

SEARCH BY CITATION